Tag Archives: breakthrough

Guest Blogspote: How to encourage pharmaceutical R&D

Politicians should only attempt the possible. We must recognise what we cannot do. The UK Government alone cannot influence the direction of R&D significantly. The sums of money involved are so vast that R&D only makes sense in a global … Continue reading

Posted in Andrew Lansley, Business, competition, Department of Health, Drugs, Health Bill, Hospitals, Innovation, NHS, Pharma, Policy, Research, Uncategorized, White Paper | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Guest BlogSpot – Which Drugs are the Most Innovative?

Andrew Lansley has recently said: “I am determined that not only will we have a reimbursement price for medicines which reflects their benefit to patients, but also one which incentivises for innovation, and supports those new medicines which respond to … Continue reading

Posted in Andrew Lansley, Department of Health, Drugs, Emerging technologies, NHS, Policy, Research, Technology, Uncategorized | Tagged , , , , , , , , , , , , , , , , , | Leave a comment